HighMark Wealth Management LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1802451 ST. PAUL, MN

Position in CRBP

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$384

+$51 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighMark Wealth Management LLC holds $19,716,398 across 37 Biotechnology names. CRBP ranks #30 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CNTA	Centessa Pharmaceuticals plc	236,785	$9,405,100
2	ANAB	Anaptysbio, Inc	94,050	$5,216,013
3	EWTX	Edgewise Therapeutics, Inc.	53,179	$1,675,138
4	XENE	Xenon Pharmaceuticals Inc.	23,000	$1,337,450
5	CRNX	Crinetics Pharmaceuticals, Inc.	20,495	$744,378
6	AUPH	Aurinia Pharmaceuticals Inc.	35,196	$521,604
7	MDXG	Mimedx Group, Inc.	55,878	$220,718
8	PLRX	Pliant Therapeutics, Inc.	166,224	$209,442

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$384	41	0.0%	Shares	Sole	2026-05-06
2025-12-31	$333	41	0.0%	Shares	Sole	2026-02-05
2025-09-30	$518	41	0.0%	Shares	Sole	2025-10-20
2025-06-30	$282	41	0.0%	Shares	Sole	2025-07-21
2025-03-31	$217	41	0.0%	Shares	Sole	2025-04-24
2024-12-31	$483	41	0.0%	Shares	Sole	2025-01-31
2024-09-30	$845	41	0.0%	Shares	Sole	2024-10-17
2024-06-30	$1,855	41	0.0%	Shares	Sole	2024-07-29
2024-03-31	$1,608	41	0.0%	Shares	Sole	2024-04-29
2023-12-31	$247	41	0.0%	Shares	Sole	2024-01-23
2023-09-30	$276	41	0.0%	Shares	Sole	2023-10-18
2023-06-30	$321	41	0.0%	Shares	Sole	2023-07-26
2023-03-31	$298	41	—	Shares	Sole	2023-04-21
No filing history on record for this holder in this stock.